市场调查报告书
商品编码
1451879
2024-2032 年按技术(生命科学试剂、分析试剂)、应用(蛋白质合成和纯化、基因表现、DNA 和 RNA 分析、药物测试等)和地区分類的生物技术试剂市场报告Biotechnology Reagents Market Report by Technology (Life Science Reagents, Analytical Reagents), Application (Protein Synthesis and Purification, Gene Expression, DNA and RNA Analysis, Drug Testing, and Others), and Region 2024-2032 |
2023年,全球生物技术试剂市场规模达到854.101亿美元。展望未来, IMARC Group预计到2032年市场规模将达到1,658.195亿美元,2024-2032年复合年增长率(CAGR)为7.42%。生命科学领域研发(R&D)活动的增加、对个人化医疗和标靶治疗的需求不断增长、基因组学和蛋白质组学研究的快速进步以及慢性病和传染病患者病率的激增是推动这一趋势的一些关键因素。市场。
生物技术试剂在生命科学领域发挥关键作用,促进了各种研究和诊断应用。它们是生物技术过程中使用的重要组成部分,可实现生物分子和系统的分离、分析和操作。它们透过细緻的製造工艺製成,旨在提供准确可靠的结果,确保实验和研究的进展和成功。生物技术试剂的主要优势之一是其在生命科学多个学科中的多功能性和广泛适用性。它们被用于各种研究领域,如基因组学、蛋白质组学、细胞生物学、分子诊断和药物发现,因为它们使科学家能够提取和纯化脱氧核糖核酸(DNA)、核糖核酸(RNA) 和蛋白质,以及进行分析、检测生物标记并进行基因表现研究。生物技术试剂也促进新治疗药物、疫苗和个人化药物的开发,促进医疗保健和疾病治疗的进步。
全球生物技术试剂市场受到多种因素的推动,包括生命科学领域不断增加的研发 (R&D) 活动以及对个人化医疗和标靶治疗的需求不断增长。此外,基因组学和蛋白质组学研究的快速进步以及慢性病和传染病患者病率的激增正在加速市场的成长。除此之外,生物技术和分子生物学的技术进步以及製药和生物技术行业的扩张正在为市场成长提供动力。此外,对医疗基础设施和政府倡议的投资以及对研究项目的资助的迅速增长也是推动增长的因素。与此一致的是,学术机构和行业参与者之间不断升级的合作以及对分子诊断的认识和采用的不断提高正在支持市场的成长。此外,生物资讯学和计算生物学的出现以及生物样本库和生物样本库设施的扩展正在促进市场成长。其他因素,例如对获得准确实验结果的高品质试剂的需求激增、农业中对基因改造生物(GMO)的需求不断增加,以及针对新兴应用(例如CRISPR/Cas9 基因编辑)开发新型试剂,都是正面的因素。为市场成长做出贡献。
The global biotechnology reagents market size reached US$ 85,410.1 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 165,819.5 Million by 2032, exhibiting a growth rate (CAGR) of 7.42% during 2024-2032. Increasing research and development (R&D) activities in the life sciences sector, the growing demand for personalized medicine and targeted therapies, the rapid advancements in genomics and proteomics research, and the surging prevalence of chronic and infectious diseases represent some of the key factors driving the market.
Biotechnology reagents play a pivotal role in the field of life sciences, facilitating various research and diagnostic applications. They are vital components used in biotechnology processes to enable the isolation, analysis, and manipulation of biological molecules and systems. They are made through meticulous manufacturing processes and are designed to provide accurate and reliable results, ensuring the progress and success of experiments and investigations. One of the key advantages of biotechnology reagents is their versatility and broad applicability across multiple disciplines within the life sciences. They are utilized in various research areas, such as genomics, proteomics, cell biology, molecular diagnostics, and drug discovery, as they enable scientists to extract and purify deoxyribonucleic acid (DNA), ribonucleic acid (RNA), and proteins, as well as perform assays, detect biomarkers, and conduct gene expression studies. Biotechnology reagents also facilitate the development of new therapeutic drugs, vaccines, and personalized medicines, contributing to advancements in healthcare and the treatment of diseases.
The global biotechnology reagents market is bolstered by numerous factors, including the increasing research and development (R&D) activities in the life sciences sector and the growing demand for personalized medicine and targeted therapies. Moreover, the rapid advancements in genomics and proteomics research and the surging prevalence of chronic and infectious diseases are accelerating the market growth. Besides this, the technological advancements in biotechnology and molecular biology and the expansion of pharmaceutical and biotechnology industries are providing an impetus to the market growth. Additionally, the burgeoning investments in healthcare infrastructure and government initiatives and funding for research projects are other growth-inducing factors. In line with this, the escalating collaborations between academic institutions and industry players and growing awareness and adoption of molecular diagnostics are supporting the market growth. Furthermore, the emergence of bioinformatics and computational biology and the expansion of biobanking and biorepository facilities are augmenting the market growth. Other factors, such as the surging demand for high-quality reagents for accurate experimental results, escalating demand for genetically modified organisms (GMOs) in agriculture, and the development of novel reagents for emerging applications, such as CRISPR/Cas9 gene editing, are positively contributing to the market growth.
IMARC Group provides an analysis of the key trends in each segment of the global biotechnology reagents market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on technology and application.
Life Science Reagents
PCR
Cell Culture
Hematology
In-Vitro Diagnostics
Others
Analytical Reagents
Chromatography
Mass Spectrometry
Electrophoresis
Flow Cytometry
Others
A detailed breakup and analysis of the biotechnology reagents market based on the technology has also been provided in the report. This includes life science reagents (PCR, cell culture, hematology, In-Vitro diagnostics, and others) and analytical reagents (chromatography, mass spectrometry, electrophoresis, flow cytometry, and others).
Protein Synthesis and Purification
Gene Expression
DNA and RNA Analysis
Drug Testing
Others
A detailed breakup and analysis of the biotechnology reagents market based on the application has also been provided in the report. This includes protein synthesis and purification, gene expression, DNA and RNA analysis, drug testing, and others.
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for biotechnology reagents. Some of the factors driving the North America biotechnology reagents market included the surging applications of biotechnology in environmental monitoring and remediation, the development of novel reagents for emerging applications, such as CRISPR/Cas9 gene editing, and the expansion of the biotechnology industry.
The report has also provided a comprehensive analysis of the competitive landscape in the global biotechnology reagents market. Detailed profiles of all major companies have been provided. Some of the companies covered include Agilent Technologies Inc., Beckman Coulter Inc. (Danaher Corporation), Becton Dickinson and Company, bioMerieux SA, Bio-Rad Laboratories Inc., Illumina Inc., Lonza Group AG, Merck KGaA, Meridian Bioscience Inc. (SD Biosensor), PerkinElmer Inc., Promega Corporation, Thermo Fisher Scientific Inc., and Waters Corporation etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.